IgA nephropathy: an overview of the disease, its pathophysiology, and involvement of the gut-kidney axis. [PDF]
Cheung CK, Mariani LH.
europepmc +1 more source
TLR7/9-mediated mucosal innate immune dysregulation in IgA nephropathy. [PDF]
Lee M, Suzuki H, Makita Y, Suzuki Y.
europepmc +1 more source
Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy. [PDF]
Zhou T, Zhang H, Liu S, Ji Y, Lv W.
europepmc +1 more source
The Three Faces of IgA Nephropathy: Clinicopathological Heterogeneity and Urinary Albumin-to-Protein Ratio in a Case Series. [PDF]
Masajtis-Zagajewska A +2 more
europepmc +1 more source
Guiding immunotherapy based on the oxford classification activity score in IgA nephropathy. [PDF]
Nong J +6 more
europepmc +1 more source
Management strategies for post-transplant IgA nephropathy in kidney transplant recipients: a scoping review. [PDF]
Bell S +4 more
europepmc +1 more source
Tonsillar Tfh cells contribute to the pathogenesis of IgA nephropathy in collaboration with memory B cells. [PDF]
Sugaya T +10 more
europepmc +1 more source
Shared genetic architecture between Crohn's disease and IgA nephropathy: implications for a gut-immune-kidney axis. [PDF]
Su T +12 more
europepmc +1 more source

